Clinical Trials & Research

A new analysis of 16 years of publicly accessible health data on 68.5 million Medicare enrollees provides broad evidence that long-term exposure to fine particles in the air – even at levels below current EPA standards – leads to increased mortality rates among the elderly. Based on the results of five complementary statistical models, including
0 Comments
Print this page CAMBRIDGE, Mass., June 24, 2020 (GLOBE NEWSWIRE) – Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that it received early notification from the U.S. Food and Drug Administration (FDA) that the company may proceed with initiating a Phase 3,
0 Comments
Jun 26 2020 Researchers from the University of Tsukuba have identified a novel protein complex that regulates Aurora B localization to ensure that chromosomes are correctly separated during cell division It is no secret that DNA, in the form of chromosomes, is the building block of life. Incorrect distribution of chromosomes during cell division can
0 Comments
Print this page 24 June 2020 — Full results from the positive Phase III ETHOS trial showed AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) demonstrated a statistically significant reduction in the rate of moderate or severe exacerbations compared with two dual-combination therapies in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).1 Compared
0 Comments
Reviewed by Emily Henderson, B.Sc.Jun 24 2020 In the future, taking your blood pressure medication could be as simple as eating a spoonful of rice. This “treatment” could also have fewer side effects than current blood pressure medicines. As a first step, researchers reporting in ACS’ Journal of Agricultural and Food Chemistry have made transgenic
0 Comments
Reviewed by Emily Henderson, B.Sc.Jun 22 2020 Lancaster University is spearheading a unique, automated, social distancing and way-finding model for businesses preparing to re-open safely in the post-pandemic recovery. The new model, devised by the University’s new School of Architecture, uses algorithms, special design exploration processes, generative software, sympathetic signage, electronically created floorplans and heat
0 Comments